5,011 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
AGRO or CTVA: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2285504/agro-or-ctva-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2285504 Jun 07, 2024 - AGRO vs. CTVA: Which Stock Is the Better Value Option?
JHG or BLK: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2285506/jhg-or-blk-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2285506 Jun 07, 2024 - JHG vs. BLK: Which Stock Is the Better Value Option?
SSRM or WPM: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2285509/ssrm-or-wpm-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2285509 Jun 07, 2024 - SSRM vs. WPM: Which Stock Is the Better Value Option?
Reasons to Add CenterPoint (CNP) to Your Portfolio Right Now https://www.zacks.com/stock/news/2285513/reasons-to-add-centerpoint-cnp-to-your-portfolio-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2285513 Jun 07, 2024 - CenterPoint (CNP) makes a strong case for investment, given well-chalked out investment plan, regular dividend payment and rising earnings estimates.
Reasons to Retain Equifax (EFX) Stock in Your Portfolio Now https://www.zacks.com/stock/news/2285570/reasons-to-retain-equifax-efx-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2285570 Jun 07, 2024 - Acquisitions enable Equifax (EFX) to provide a broad insight into consumer performance, financial status, capabilities of customers and market opportunities.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now https://www.zacks.com/stock/news/2285553/reasons-to-retain-fresenius-medical-fms-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2285553 Jun 07, 2024 - Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Reasons to Add Masimo (MASI) Stock to Your Portfolio Now https://www.zacks.com/stock/news/2285554/reasons-to-add-masimo-masi-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2285554 Jun 07, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
Cocrystal Pharma, Inc. (COCP) Now Trades Above Golden Cross: Time to Buy? https://www.zacks.com/stock/news/2285338/cocrystal-pharma-inc-cocp-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2285338 Jun 07, 2024 - When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
XFLT.PR.A: With The Shares Close To Par, This Is A Hold Now (Rating Downgrade) https://seekingalpha.com/article/4698018-xfltpra-with-the-shares-close-to-par-this-is-a-hold-now-xflt-stock?source=feed_tag_etf_portfolio_strategy Jun 07, 2024 -
Are Investors Undervaluing Burlington Stores (BURL) Right Now? https://www.zacks.com/stock/news/2285268/are-investors-undervaluing-burlington-stores-burl-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2285268 Jun 07, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
<<<Page 206>